☰

Devin T. Wiley, Ph.D. - Publications

Affiliations: 
2013 Chemical Engineering California Institute of Technology, Pasadena, CA 
Area:
Catalysis, Molecular Therapy
Tree Info Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Chao J, Lin J, Frankel P, Clark AJ, Wiley DT, Garmey E, Fakih M, Lim D, Chung V, Luevanos E, Eliasof S, Davis ME, Yen Y. Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancer. Journal of Gastrointestinal Oncology. 8: 962-969. PMID 29299355 DOI: 10.21037/Jgo.2017.08.10  0.669
2016 Clark AJ, Wiley DT, Zuckerman JE, Webster P, Chao J, Lin J, Yen Y, Davis ME. CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing. Proceedings of the National Academy of Sciences of the United States of America. PMID 27001839 DOI: 10.1073/Pnas.1603018113  0.638
2016 Chao J, Lin J, Frankel PH, Clark AJ, Wiley DT, Garmey EG, Fakih M, Lim D, Chung VM, Luevanos E, Eliasof S, Davis ME, Yen Y. Pilot trial of CRLX101 in patients (pts) with advanced, chemotherapy-refractory gastroesophageal cancer (GEC). Journal of Clinical Oncology. 34: 44-44. DOI: 10.1200/Jco.2016.34.4_Suppl.44  0.587
2015 Clark A, Wiley DT, Zuckerman JE, Webster P, Chao J, Lin J, Yen Y, Davis ME, Eliasof S. Abstract B33: CRLX101, an investigational nanoparticle-drug conjugate, localizes in human tumors and not in adjacent healthy tissue after intravenous dosing Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-B33  0.643
2013 Eliasof S, Lazarus D, Peters CG, Case RI, Cole RO, Hwang J, Schluep T, Chao J, Lin J, Yen Y, Han H, Wiley DT, Zuckerman JE, Davis ME. Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle. Proceedings of the National Academy of Sciences of the United States of America. 110: 15127-32. PMID 23980155 DOI: 10.1073/Pnas.1309566110  0.585
2013 Wiley DT, Webster P, Gale A, Davis ME. Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. Proceedings of the National Academy of Sciences of the United States of America. 110: 8662-7. PMID 23650374 DOI: 10.1073/Pnas.1307152110  0.515
Show low-probability matches.